Found: 17
Select item for more details and to access through your institution.
Clinical Significance of Promoter Hypermethylation of ERβ and RARβ2 in Tumor and Serum DNA in Indian Breast Cancer Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 9, p. 3107, doi. 10.1245/s10434-012-2323-5
- By:
- Publication type:
- Article
Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2838, doi. 10.3390/cancers12102838
- By:
- Publication type:
- Article
Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11387-z
- By:
- Publication type:
- Article
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 159, n. 3, p. 457, doi. 10.1007/s10549-016-3967-9
- By:
- Publication type:
- Article
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 150, n. 1, p. 91, doi. 10.1007/s10549-015-3308-4
- By:
- Publication type:
- Article
Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 137, n. 3, p. 721, doi. 10.1007/s10549-012-2363-3
- By:
- Publication type:
- Article
Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 171, doi. 10.1007/s10549-011-1946-8
- By:
- Publication type:
- Article
ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
- Published in:
- Breast Cancer Research, 2016, v. 18, p. 1, doi. 10.1186/s13058-016-0770-9
- By:
- Publication type:
- Article
Correction: Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04292-3
- By:
- Publication type:
- Article
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04292-3
- By:
- Publication type:
- Article
Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
- Published in:
- Molecular & Cellular Biochemistry, 2010, v. 342, n. 1/2, p. 101, doi. 10.1007/s11010-010-0473-y
- By:
- Publication type:
- Article
EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.81288
- By:
- Publication type:
- Article
Mutant PIK3CA Induces EMT in a Cell Type Specific Manner.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0167064
- By:
- Publication type:
- Article
Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 22, p. 3664, doi. 10.3390/cells11223664
- By:
- Publication type:
- Article
Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low‐Concentration Collagen‐Based Bioinks.
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 26, p. 1, doi. 10.1002/adhm.202300905
- By:
- Publication type:
- Article
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05125-1
- By:
- Publication type:
- Article